JP2023093634A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023093634A5 JP2023093634A5 JP2023069317A JP2023069317A JP2023093634A5 JP 2023093634 A5 JP2023093634 A5 JP 2023093634A5 JP 2023069317 A JP2023069317 A JP 2023069317A JP 2023069317 A JP2023069317 A JP 2023069317A JP 2023093634 A5 JP2023093634 A5 JP 2023093634A5
- Authority
- JP
- Japan
- Prior art keywords
- kda
- seq
- fusion protein
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810481941 | 2018-05-18 | ||
| CN201810481941.X | 2018-05-18 | ||
| JP2020564649A JP2021530437A (ja) | 2018-05-18 | 2019-05-16 | 改良されたｆｖｉｉｉ融合タンパク質及びその応用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564649A Division JP2021530437A (ja) | 2018-05-18 | 2019-05-16 | 改良されたｆｖｉｉｉ融合タンパク質及びその応用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023093634A JP2023093634A (ja) | 2023-07-04 |
| JP2023093634A5 true JP2023093634A5 (https=) | 2023-08-16 |
| JP7492780B2 JP7492780B2 (ja) | 2024-05-30 |
Family
ID=68539524
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564649A Pending JP2021530437A (ja) | 2018-05-18 | 2019-05-16 | 改良されたｆｖｉｉｉ融合タンパク質及びその応用 |
| JP2023069317A Active JP7492780B2 (ja) | 2018-05-18 | 2023-04-20 | 改良されたｆｖｉｉｉ融合タンパク質及びその応用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564649A Pending JP2021530437A (ja) | 2018-05-18 | 2019-05-16 | 改良されたｆｖｉｉｉ融合タンパク質及びその応用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12440572B2 (https=) |
| EP (1) | EP3816181A4 (https=) |
| JP (2) | JP2021530437A (https=) |
| KR (1) | KR102575788B1 (https=) |
| CN (2) | CN117467019A (https=) |
| BR (1) | BR112020023168A2 (https=) |
| MA (1) | MA53020A (https=) |
| MX (1) | MX2020012103A (https=) |
| WO (1) | WO2019219049A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025521136A (ja) * | 2022-05-25 | 2025-07-08 | チアンスー ジェンサイエンス インコーポレイテッド | 半減期が延長されたｆｖｉｉｉ融合タンパク質コンジュゲート及びその応用 |
| CN116284411B (zh) * | 2023-02-03 | 2024-02-13 | 北京基科晟斯医药科技有限公司 | 抗培重组人凝血因子VIII-Fc融合蛋白的抗体及其应用 |
| CN116036244B (zh) * | 2023-02-24 | 2023-09-19 | 北京基科晟斯医药科技有限公司 | 培重组人凝血因子VIII-Fc融合蛋白用于治疗含抑制物的血友病A的用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818679A (en) | 1985-02-19 | 1989-04-04 | The Trustees Of Columbia University In The City Of New York | Method for recovering mutant cells |
| AU6029594A (en) | 1993-01-15 | 1994-08-15 | Enzon, Inc. | Factor viii - polymeric conjugates |
| JP2001510053A (ja) | 1997-07-18 | 2001-07-31 | カイロン コーポレイション | レンチウイルスベクター |
| KR101468345B1 (ko) | 2004-11-12 | 2014-12-03 | 바이엘 헬스케어 엘엘씨 | Ｆｖｉｉｉ의 부위 지향 변형 |
| EP1891231A4 (en) | 2005-05-25 | 2011-06-22 | Novo Nordisk As | GLYCOPEGYLATED FACTOR IX |
| US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
| WO2010083536A1 (en) | 2009-01-19 | 2010-07-22 | Bayer Healthcare Llc | Protein conjugate having an endopeptidase-cleavable bioprotective moiety |
| CN105153313A (zh) * | 2010-02-16 | 2015-12-16 | 诺沃—诺迪斯克有限公司 | 因子viii融合蛋白 |
| US20130040888A1 (en) | 2010-02-16 | 2013-02-14 | Novo Nordisk A/S | Factor VIII Molecules With Reduced VWF Binding |
| GB201007357D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIII |
| CN103917554B (zh) | 2011-10-18 | 2017-03-08 | 杰特有限公司 | 用于改善重构后纯化的因子viii的稳定性的方法 |
| CN103172745A (zh) | 2011-12-21 | 2013-06-26 | 北京韩美药品有限公司 | 包含免疫球蛋白Fc片段的长效人内皮抑素 |
| DK2804623T3 (da) * | 2012-01-12 | 2019-11-11 | Bioverativ Therapeutics Inc | Kimære faktor viii-polypeptider og anvendelser deraf |
| EP3404105A1 (en) * | 2012-07-06 | 2018-11-21 | Bioverativ Therapeutics Inc. | Cell line expressing single chain factor viii polypeptides and uses thereof |
| JP2015527350A (ja) | 2012-08-13 | 2015-09-17 | ノヴォ ノルディスク アー／エス | 第ｖｉｉｉ因子の液体製剤 |
| WO2014100913A1 (en) | 2012-12-24 | 2014-07-03 | Beijing Anxinhuaide Biotech. Co., Ltd | Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer |
| EP2796145B1 (en) | 2013-04-22 | 2017-11-01 | CSL Ltd. | A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge |
| CN103539860B (zh) | 2013-11-01 | 2014-12-03 | 广州优联康医药科技有限公司 | 一种长效重组人促卵泡激素融合蛋白 |
| JP6851381B6 (ja) | 2016-01-07 | 2021-04-21 | ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト | 変異切断型フォンウィルブランド因子 |
| CN109790529A (zh) * | 2016-06-24 | 2019-05-21 | 财团法人牧岩生命科学研究所 | 包含FVIII和vWF因子的嵌合蛋白及其用途 |
| CN106279437B (zh) | 2016-08-19 | 2017-10-31 | 安源医药科技（上海）有限公司 | 高糖基化人凝血因子viii融合蛋白及其制备方法与用途 |
-
2019
- 2019-05-16 US US17/055,403 patent/US12440572B2/en active Active
- 2019-05-16 BR BR112020023168-1A patent/BR112020023168A2/pt unknown
- 2019-05-16 WO PCT/CN2019/087156 patent/WO2019219049A1/zh not_active Ceased
- 2019-05-16 JP JP2020564649A patent/JP2021530437A/ja active Pending
- 2019-05-16 KR KR1020207034852A patent/KR102575788B1/ko active Active
- 2019-05-16 MX MX2020012103A patent/MX2020012103A/es unknown
- 2019-05-16 CN CN202310860049.3A patent/CN117467019A/zh active Pending
- 2019-05-16 CN CN201980033170.0A patent/CN113039200B/zh active Active
- 2019-05-16 EP EP19804136.0A patent/EP3816181A4/en active Pending
- 2019-05-16 MA MA053020A patent/MA53020A/fr unknown
-
2023
- 2023-04-20 JP JP2023069317A patent/JP7492780B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023093634A5 (https=) | ||
| TWI250988B (en) | Thrombopoietic compounds | |
| US6072041A (en) | Fusion proteins for protein delivery | |
| JP2005525302A5 (https=) | ||
| JP2020508691A5 (https=) | ||
| JP2011518179A5 (https=) | ||
| RU2183215C2 (ru) | Конъюгат для стимулирования иммунной реакции против клетки-мишени, способ лечения злокачественных опухолей у млекопитающего | |
| ES2271954T3 (es) | Expresion de lipoproteinas. | |
| JP2010515686A5 (https=) | ||
| CN101622271A (zh) | 新型抗微生物肽 | |
| WO1991019515A1 (en) | Oligomeric immunoglobulin constant domain mutant with enhanced complement-mediated cytolytic activity | |
| JP2015504675A5 (https=) | ||
| JP2765807B2 (ja) | Ｇ−ｃｓｆ及びｔｎｆ結合タンパク質を含む産生物 | |
| JP2009520758A5 (https=) | ||
| RU2007119989A (ru) | Композиции, слитые конструкции и конъюгаты plad домена | |
| JP2006523709A5 (https=) | ||
| JP2014088402A (ja) | Ｃ末端におけるポリペプチドの結合 | |
| JP2003530871A (ja) | インテグリン／接着因子アンタゴニスト | |
| JPWO2021235553A5 (https=) | ||
| JPH08504210A (ja) | 結合生物活性ペプチドを使用した敗血症性ショックの治療 | |
| JPWO2021092081A5 (https=) | ||
| JP2002513802A5 (https=) | ||
| JP2008133206A (ja) | 緑膿菌に対して感染防御能を誘導できる医薬組成物 | |
| CA2581110A1 (en) | Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions | |
| US7011968B1 (en) | Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |